These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 24524898)

  • 21. Targeting nevirapine delivery across human brain microvascular endothelial cells using transferrin-grafted poly(lactide-co-glycolide) nanoparticles.
    Kuo YC; Lin PI; Wang CC
    Nanomedicine (Lond); 2011 Aug; 6(6):1011-26. PubMed ID: 21707298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Probing and Enhancing Ligand-Mediated Active Targeting of Tumors Using Sub-5 nm Ultrafine Iron Oxide Nanoparticles.
    Xu Y; Wu H; Huang J; Qian W; Martinson DE; Ji B; Li Y; Wang YA; Yang L; Mao H
    Theranostics; 2020; 10(6):2479-2494. PubMed ID: 32194814
    [No Abstract]   [Full Text] [Related]  

  • 23. Physicochemical and biological characterization of targeted, nucleic acid-containing nanoparticles.
    Bartlett DW; Davis ME
    Bioconjug Chem; 2007; 18(2):456-68. PubMed ID: 17326672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transferrin-mediated fullerenes nanoparticles as Fe(2+)-dependent drug vehicles for synergistic anti-tumor efficacy.
    Zhang H; Hou L; Jiao X; Ji Y; Zhu X; Zhang Z
    Biomaterials; 2015 Jan; 37():353-66. PubMed ID: 25453964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transferrin modified graphene oxide for glioma-targeted drug delivery: in vitro and in vivo evaluations.
    Liu G; Shen H; Mao J; Zhang L; Jiang Z; Sun T; Lan Q; Zhang Z
    ACS Appl Mater Interfaces; 2013 Aug; 5(15):6909-14. PubMed ID: 23883622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brain delivery and cellular internalization mechanisms for transferrin conjugated biodegradable polymersomes.
    Pang Z; Gao H; Yu Y; Chen J; Guo L; Ren J; Wen Z; Su J; Jiang X
    Int J Pharm; 2011 Aug; 415(1-2):284-92. PubMed ID: 21651966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetically engineering transferrin to improve its in vitro ability to deliver cytotoxins.
    Yoon DJ; Chu DS; Ng CW; Pham EA; Mason AB; Hudson DM; Smith VC; MacGillivray RT; Kamei DT
    J Control Release; 2009 Feb; 133(3):178-84. PubMed ID: 18992290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surface engineered polymeric nanocarriers mediate the delivery of transferrin-methotrexate conjugates for an improved understanding of brain cancer.
    Jain A; Jain A; Garg NK; Tyagi RK; Singh B; Katare OP; Webster TJ; Soni V
    Acta Biomater; 2015 Sep; 24():140-51. PubMed ID: 26116986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paclitaxel-loaded PLGA nanoparticles surface modified with transferrin and Pluronic((R))P85, an in vitro cell line and in vivo biodistribution studies on rat model.
    Shah N; Chaudhari K; Dantuluri P; Murthy RS; Das S
    J Drug Target; 2009 Aug; 17(7):533-42. PubMed ID: 19530913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ligand-targeted particulate nanomedicines undergoing clinical evaluation: current status.
    van der Meel R; Vehmeijer LJ; Kok RJ; Storm G; van Gaal EV
    Adv Drug Deliv Rev; 2013 Oct; 65(10):1284-98. PubMed ID: 24018362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transferrin-Conjugated Nanocarriers as Active-Targeted Drug Delivery Platforms for Cancer Therapy.
    Nogueira-Librelotto DR; Codevilla CF; Farooqi A; Rolim CM
    Curr Pharm Des; 2017; 23(3):454-466. PubMed ID: 27784246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein functionalized tramadol-loaded PLGA nanoparticles: preparation, optimization, stability and pharmacodynamic studies.
    Lalani J; Rathi M; Lalan M; Misra A
    Drug Dev Ind Pharm; 2013 Jun; 39(6):854-64. PubMed ID: 22799442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced intracellular delivery and chemotherapy for glioma rats by transferrin-conjugated biodegradable polymersomes loaded with doxorubicin.
    Pang Z; Gao H; Yu Y; Guo L; Chen J; Pan S; Ren J; Wen Z; Jiang X
    Bioconjug Chem; 2011 Jun; 22(6):1171-80. PubMed ID: 21528923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of transferrin-conjugated paclitaxel-loaded nanoparticles in a murine model of prostate cancer.
    Sahoo SK; Ma W; Labhasetwar V
    Int J Cancer; 2004 Nov; 112(2):335-40. PubMed ID: 15352049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mathematical modeling of mutant transferrin-CRM107 molecular conjugates for cancer therapy.
    Yoon DJ; Chen KY; Lopes AM; Pan AA; Shiloach J; Mason AB; Kamei DT
    J Theor Biol; 2017 Mar; 416():88-98. PubMed ID: 28065783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Doxorubicin-loaded human serum albumin nanoparticles surface-modified with TNF-related apoptosis-inducing ligand and transferrin for targeting multiple tumor types.
    Bae S; Ma K; Kim TH; Lee ES; Oh KT; Park ES; Lee KC; Youn YS
    Biomaterials; 2012 Feb; 33(5):1536-46. PubMed ID: 22118776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design and investigation of targeting agent orientation and density on nanoparticles for enhancing cellular uptake efficiency.
    Fei W; Wang X; Guo J; Wang C
    J Mater Chem B; 2023 Aug; 11(34):8228-8240. PubMed ID: 37565424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A dual-targeting nanocarrier based on poly(amidoamine) dendrimers conjugated with transferrin and tamoxifen for treating brain gliomas.
    Li Y; He H; Jia X; Lu WL; Lou J; Wei Y
    Biomaterials; 2012 May; 33(15):3899-908. PubMed ID: 22364698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concanavalin A-conjugated poly(ethylene glycol)-poly(lactic acid) nanoparticles for intranasal drug delivery to the cervical lymph nodes.
    Shao X; Liu Q; Zhang C; Zheng X; Chen J; Zha Y; Qian Y; Zhang X; Zhang Q; Jiang X
    J Microencapsul; 2013; 30(8):780-6. PubMed ID: 23631383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transferrin-conjugated micelles: enhanced accumulation and antitumor effect for transferrin-receptor-overexpressing cancer models.
    Yue J; Liu S; Wang R; Hu X; Xie Z; Huang Y; Jing X
    Mol Pharm; 2012 Jul; 9(7):1919-31. PubMed ID: 22616905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.